Applied Molecular Transport Inc.: M&A transaction — Applied Molecular Transport completes merger with Cyclo Therapeutics; AMTI becomes wholly owned subsidiary

Applied Molecular Transport Inc.

Each AMTI share converted into 0.1331 shares of Cyclo common stock at merger effective December 27, 2023.
AMTI requested Nasdaq to suspend trading and delist AMTI common stock; will file Form 15 to deregister.
All AMTI directors and officers ceased; former AMTI director Shawn Cross appointed to Cyclo board.
AMTI's charter and bylaws amended and restated per the Merger Agreement.

item 2.01 item 3.01 item 3.03 item 5.01 item 5.02 item 5.03 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Shawn Cross

director

Applied Molecular Transport Inc.

Effective: 2023-12-27
Filed: December 27, 2023, 6:59 PM ET

Shawn Cross, a former director of AMTI, was appointed to the board of directors of Cyclo.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Shawn Cross was appointed as director at Applied Molecular Transport Inc..

Action: appointed
Role: director

Exact text from the filing

Shawn Cross, a former director of AMTI, was appointed to the board of directors of Cyclo.

View on SEC.gov

M&A Transactions SEC 8-K Item 2.01/5.01 confidence 0.99

Applied Molecular Transport Inc. underwent a change of control involving Cyclo Therapeutics, Inc. (closed 2023-12-27).

Action: change of control
Counterparty: Cyclo Therapeutics, Inc.
Closing: 2023-12-27

Exact text from the filing

On December 27, 2023, Applied Molecular Transport Inc., a Delaware corporation ("AMTI"), completed the previously announced strategic combination contemplated by that certain Agreement and Plan of Merger, dated as of September 21, 2023 (the "Merger Agreement"), by and among Cyclo Therapeutics, Inc., a Nevada corporation ("Cyclo"), Cameo Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Cyclo ("Merger Sub") and AMTI, providing for the merger of Merger Sub with and into AMTI, with AMTI surviving the merger as a wholly-owned subsidiary of Cyclo (the "Merger").

View on SEC.gov

Browse all m&a transactions →

Source: SEC EDGAR

accession 0001437749-23-035381

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.